PTSD

Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
Fierce Biotech
Fri, 01/17/25 - 11:17 am
Lykos Therapeutics
MDMA
PTSD
MDMA Drug Developers Reprioritize Following Lykos Rejection in PTSD
BioSpace
Mon, 09/30/24 - 09:51 am
Lykos Therapeutics
MDMA
PTSD
psychedelics
Following rejection and retractions, Lykos caps off chaotic week by cutting 75% of staff
Fierce Biotech
Thu, 08/15/24 - 10:08 pm
Lykos Therapeutics
layoffs
MDMA
PTSD
Article retractions muddy MDMA waters after FDA denial
Pharmaphorum
Mon, 08/12/24 - 11:23 am
MDMA
Lykos Therapeutics
PTSD
FDA
psychedelics
Lykos will ask FDA to reconsider its decision following rejection of MDMA therapy for post-traumatic stress disorder
Fierce Biotech
Sun, 08/11/24 - 01:09 pm
Lykos Therapeutics
FDA
MDMA
PTSD
midomafetamine
MDMA therapy is facing an imminent FDA decision. Here’s what you need to know
Stat
Fri, 08/9/24 - 11:29 am
FDA
MDMA
psychedelics
Lykos Therapeutics
PTSD
Lykos’ MDMA-Assisted PTSD Therapy Heads to FDA After Adcomm Setback
BioSpace
Mon, 08/5/24 - 11:06 am
Lykos Therapeutics
MDMA
PTSD
FDA
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
Fierce Biotech
Thu, 06/13/24 - 11:09 am
Lykos Therapeutics
FDA
MDMA
PTSD
FDA panel to review psychedelic drug MDMA for first time
Reuters
Tue, 06/4/24 - 11:40 am
FDA
MDMA
PTSD
psychedelic drugs
Lykos Therapeutics
Otsuka and Lundbeck report data from three PTSD treatment trials
Clinical Trials Arena
Wed, 05/29/24 - 11:52 am
Otsuka
Lundbeck
PTSD
clinical tirals
brexpiprazole-sertraline
ICER Finds ‘Substantial Uncertainties’ in Lykos’ MDMA Trials Ahead of Adcomm
BioSpace
Thu, 05/16/24 - 11:33 am
Lykos Therapeutics
ICER
PTSD
MDMA
Jazz drops PTSD drug over phase 2 trial failure
Fierce Biotech
Fri, 12/22/23 - 09:39 am
Jazz Pharma
PTSD
FAAH inhibitors
clinical trials
JZP150
Compass shows safety in first psilocybin trial for PTSD, but efficacy data still to come
Fierce Biotech
Wed, 12/20/23 - 09:30 am
Compass Therapeutics
clinical trials
psychedelic drugs
PTSD
psilocybin
Bionomics’ PTSD Candidate Clears Phase IIb Study, Stock Jumps 415%
BioSpace
Fri, 09/29/23 - 10:12 am
Bionomics
PTSD
BNC210
clinical trials
MDMA approval filing nears after drug hits again in phase 3, showing consistent PTSD improvements
Fierce Biotech
Fri, 09/15/23 - 11:43 am
MDMA
MAPS Public Benefit Corp
clinical trials
PTSD
psychedelic drugs
A bill in Congress would fund a clinical trial studying psychedelic drugs’ effects in veterans
Houston Public Media
Thu, 08/3/23 - 10:20 am
clinical trials
Texas
psychedelic drugs
veterans
PTSD
Psycheceutical starts a Phase I trial with topical ketamine
Clinical Trials Arena
Fri, 07/14/23 - 10:16 am
Psycheceutical
PTSD
clinical trials
topical ketamine
NeuroDirect
Defense Department backs new study of Idorsia's Quviviq as a treatment for PTSD
Fierce Pharma
Wed, 05/10/23 - 09:58 am
Idorsia
PTSD
Department of Defense
Quviviq
First-Of-Its-Kind Clinical Trial To Study Psychedelic Treatments For PTSD In Veterans
Forbes
Wed, 08/12/20 - 11:49 pm
psychedelic drugs
clinical trials
PTSD
NeuroPharm
Mydecine Innovations
veterans

Pages